MBX Biosciences (MBX) Amortizatization of Intangibles (2023 - 2026)

MBX Biosciences has reported Amortizatization of Intangibles over the past 4 years, most recently at $579000.0 for Q1 2026.

  • Quarterly results put Amortizatization of Intangibles at $579000.0 for Q1 2026, down 56.89% from a year ago — trailing twelve months through Mar 2026 was $2.8 million (down 24.44% YoY), and the annual figure for FY2025 was $3.6 million, up 23.33%.
  • Amortizatization of Intangibles reached $579000.0 in Q1 2026 per MBX's latest filing, up from $555000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $1.4 million in Q4 2024 and bottomed at $441000.0 in Q2 2024.
  • Median Amortizatization of Intangibles over the past 4 years was $593500.0 (2023), compared with a mean of $771800.0.
  • Peak annual rise in Amortizatization of Intangibles hit 167.0% in 2025, while the deepest fall reached 60.27% in 2025.
  • Over 4 years, Amortizatization of Intangibles stood at $600000.0 in 2023, then surged by 132.83% to $1.4 million in 2024, then crashed by 60.27% to $555000.0 in 2025, then grew by 4.32% to $579000.0 in 2026.
  • Business Quant data shows Amortizatization of Intangibles for MBX at $579000.0 in Q1 2026, $555000.0 in Q4 2025, and $734000.0 in Q3 2025.